Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone

Scand J Rheumatol. 2010 Aug;39(4):349-50. doi: 10.3109/03009740903493741.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Cyclophosphamide / therapeutic use*
  • Disease Progression
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Methylprednisolone / therapeutic use*
  • Myocarditis / drug therapy*
  • Myocarditis / etiology
  • Scleroderma, Diffuse / complications
  • Scleroderma, Diffuse / drug therapy*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Cyclophosphamide
  • Methylprednisolone